Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2003 Jul;41(7):3336–3338. doi: 10.1128/JCM.41.7.3336-3338.2003

Comparison of Genotyping Helicobacter pylori Directly from Biopsy Specimens and Genotyping from Bacterial Cultures

Chang-Young Park 1,2, Minjung Kwak 3, Oscar Gutierrez 4, David Y Graham 1, Yoshio Yamaoka 1,*
PMCID: PMC165374  PMID: 12843087

Abstract

PCR for vacA and cagA genotypes of Helicobacter pylori using DNA isolated from infected gastric biopsy specimens was approximately equal to genotyping using bacterial DNA from cultures. Inconsistent results were associated with low H. pylori density in biopsies. A higher proportion of mixed infection was found when biopsies were used.


Peptic ulcer or gastric cancer is most likely associated with cag pathogenicity island (PAI)-positive Helicobacter pylori strains (3, 4). Although attempts to associate specific mosaic combinations of signal sequences (s1a, s1b, s1c, and s2) and middle region allelic types (m1 and m2) of the vacA gene have met with little success, there is interest in genotyping H. pylori in relation to this factor (1, 8, 11). This study was undertaken to determine whether genotyping with DNA extracted from gastric biopsy specimens provided results similar to those with bacterial DNA isolated from H. pylori cultured from gastric biopsies.

DNA from serial dilutions of H. pylori cells (0 to 106 bacteria per PCR) from strains ATCC 43504 (vacA s1a-m1, cagA positive), ATCC 51932 (vacA s2-m2, cagA negative) and C90 (vacA s1b-m1, cagA positive) was used to define the accuracy of the cagA and vacA PCR assays (Table 1). PCR amplification was performed as previously described (11). PCR products with the expected band size were regarded as positive for the target genes. PCR for the cag empty site was used to confirm the absence of the entire cag PAI (6). If both cagA and empty site PCRs were positive, the sample was scored as a mixed cagA-positive and cagA (or cag PAI)-negative infection. If both cagA and empty site PCRs were negative, the samples were recorded as having no band (NB). Genotyping with bacterial DNA was possible with as few as 10 bacteria per PCR, although the cag empty site required 100 bacteria per PCR (Table 2). The specificity of the PCR assay was confirmed with 37 related and unrelated bacteria, including 3 Helicobacter species and 4 Campylobacter species (5). All primers proved specific for H. pylori.

TABLE 1.

PCR primers for amplification of cagA and vacA sequences

Gene and DNA region amplified Primer Primer sequence (5′→3′)a PCR product size (bp) Reference
cagA CAGAF GATAACAGGCAAGCTTTTGAGG 349 11
CAGAR CTGCAAAAGATTGTTTGGCAGA 11
cagA CAGA5F GGCAATGGTGGTCCTGGAGCTAGGC 325 6
CAGA5R GGAAATCTTTAATCTCAGTTCGG 6
cag empty site Luni1 ACATTTTGGCTAAATAAACGCTG 550 6
R5280 GGTTGCACGCATTTTCCCTTAATC 6
vacA s1 VA1-F ATGGAAATACAACAAACACAC 259 1
VA1-R CTGCTTGAATGCGCCAAAC 1
vacA s2 VA1-F ATGGAAATACAACAAACACAC 286 1
VA1-R CTGCTTGAATGCGCCAAAC 1
vacA s1a S1A-Fb TCTYGCTTTAGTAGGAGC 212 9
vacA s1b SS3-Fb AGCGCCATACCGCAAGAG 187 1
vacA m1 VAG-F CAATCTGTCCAATCAAGCGAG 570 11
VAG-R GCGTCTAAATAATTCCAAGG 11
vacA m2 VAG-F CAATCTGTCCAATCAAGCGAG 645 11
VAG-R GCGTCTAAATAATTCCAAGG 11
a

Y = C + T.

b

Used with primer VA1-R.

TABLE 2.

Limits of detection of each primer in two different specimens for PCR

DNA Limit of detection (CFU/PCR) fora:
vacA
cagA
cag empty site vacA
s1/s2 m1/m2 5′ region Middle region s1a s1b
Bacterial 10 10 10 10 100 10 10
Bacteria/tissue 10 100 100 100 100 10 100
a

Each value represents the minimum amount of H. pylori (CFU) per PCR that could be detected by PCR.

We simulated mucosal biopsies by adding approximately 50 mg of noninfected gastric mucosal tissues to each of 96 wells of a microtiter plate along with serial dilutions of H. pylori suspended in RPMI 1640 medium (Invitrogen Corp., Carlsbad, Calif.). After 2 h of incubation at 37°C with 5% CO2 to enhance attachment and bacterial tissue interactions, samples in the plates were centrifuged at 12,000 × g for 1 min, the supernatants were discarded, and DNA was extracted from the pellets by using the QIAamp tissue kit (QIAGEN, Inc.) (spiked-tissue experiment). Tissue DNA without added H. pylori served as negative controls, and no PCR bands were detected, again confirming specificity for H. pylori. With the exception for genotypes of vacA s, vacA s1a, and the cag empty site, PCR using simulated biopsy tissue required a minimum of 10 times more DNA than genotyping using bacterial DNA (Table 2).

We simulated mixed infection by adding approximately 50 mg of noninfected gastric mucosal tissues to each of 96 wells along with two different genotypes of H. pylori (103 to 105 CFU of each strain) suspended in RPMI 1640 medium (Invitrogen). This number of bacteria was based on our prior experience and published data showing that the concentration of H. pylori in gastric mucosal biopsies was typically in the range of 5 × 103 to 5 × 105 bacteria per biopsy sample (2, 10). We used two vacA s1a-m1, cagA-positive strains (ATCC 43504 and JK31), two vacA s1b-m1, cagA-positive strains (C90 and C91), and two vacA s2-m2, cagA-negative strains (ATCC 51932 and C94) for the mixed spiked-tissue experiments. For each genotype, we tested one fast-growing strain and one slow-growing strain based on the time required to reach a plateau in liquid culture.

Using a starting bacterial dose of approximately 106 bacteria, fast growers required approximately 10 h, and slow growers required approximately 30 h to reach the same cell density. Samples were handled as described above (in vitro spiked-tissue experiment). Homogenized tissues were cultured before DNA extraction, and DNA corresponding to 106 bacteria from multiple colonies was used for each PCR. In the mixed spiked-tissue experiment, we could detect both genotypes irrespective of the rate of growth and the starting dilution (103 and 105 [1:100] to 105 and 103 [100:1]). However, genotyping results following coculture of fast- and slow-growing strains was observed to be dependent on both the rate of growth and the starting dilution (Table 3). Only when the before-culture growth ratio (slow/fast) of the two strains was 1% or less were the results other than “mixed culture.” When we used two strains with the same growth speed (fast or slow), we could correctly genotype the strains irrespective of the starting ratios, which varied between 1:100 and 100:1.

TABLE 3.

Effects of mixed infection in in vitro study of different concentrations of each strain

Mixed culturea Result for strain concn at ratiob:
1:1 (104:104) 1:10 (103:104) 1:100 (103:105) 10:1 (104:103) 100:1 (105:103)
vacA s1-m1-cagA+ (slow)-     vacA s2-m2-cagA− (fast)
    s Mixed Mixed s2 Mixed Mixed
    m Mixed Mixed s2 Mixed Mixed
    cagA Mixed Mixed Negative Mixed Mixed
vacA s2-m2-cagA− (slow)-     vacA s1-m1-cagA+ (fast)
    s Mixed Mixed s1 Mixed Mixed
    m Mixed Mixed s1 Mixed Mixed
    cagA Mixed Mixed Positive Mixed mixed
vacA s1b-m1-cagA+ (slow)-     vacA s1a-m1-cagA+ (fast)
    s1 subtype Mixed Mixed s1a Mixed Mixed
vacA s1a-m1-cagA+ (slow)-     vacA s1b-m1-cagA+ (fast)
    s1 subtype Mixed Mixed s1b Mixed Mixed
a

+, positive; −, negative.

b

Ratio of CFU (in parentheses) from each strain when we initially made a mixture of two strains.

We finally examined the gastric mucosal biopsy specimens from 166 H. pylori culture-positive Colombian patients in which mixed infection is common (9, 12). Informed consent was obtained from all patients, and the ethics committee of Universidad Nacional de Colombia approved the protocol. Antral biopsy specimens were sent frozen on dry ice to Houston, where they were defrosted and homogenized by grinding. The wet weights were approximately 50 mg in each sample. Genomic DNA was directly extracted from biopsy specimens as described for the spiked-tissue experiments. The homogenized material was also cultured, and DNA from multiple colonies was extracted as described above. Again, DNA corresponding to 106 bacteria per PCR was used. There was good agreement between PCR-based genotyping results with tissue DNA and those with bacterial DNA, especially for vacA m1 versus m2 and vacA s1 versus s2 (Table 4). Inconsistencies between results from PCR from the biopsy samples and culture of the sample were possibly due to differences in growth rate among the strains present in the stomach or the numbers of organisms per strain. The interpretation of the results to determine which approach was superior depended on how one handled the data regarding mixed infections. Use of PCR from the biopsy specimen showed 32 cases with mixed vacA s1a and s1b strain, whereas PCR from bacteria recovered by culture revealed only 10 cases. Overall, we detected mixed infection (defined as evidence of two strains with any of the genes examined) in 27% of cases when we used tissue DNA compared to only 9% when we used bacterial DNA. In gastric cancer specimens, there was only fair-to-moderate agreement in genotyping between tissue DNA and bacterial DNA for the vacA s1 subtype, because there were many cases with mixed infection of s1a and s1b genotypes in tissue DNA (19 of 51 [37%] versus 3 of 51 [6%], respectively). Thus, studies to identify relationships between virulence factors and disease presentation (e.g., gastric cancer) should be restricted to sites where mixed infection is uncommon. However, excluding mixed infections when they are common might produce a misleading perception of the actual relationships of bacterial strains to pathology of the diseases (8).

TABLE 4.

PCR results from tissue DNA compared with culture DNA

Genotype (n) No. (%) with NB by biopsy No. of mixed infections by biopsy No. (%) with identical result for mixed infections No. of inconsistent cases (different genotypes) No. (%) with identical result Overall accuracy (%)a
cagA (166) 14 (8.4) 3 0 (0)b 1 148 (97.4)c 89.2
vacA m1, 2 (166) 5 (3.0) 9 5 (55) 1 156 (96.9) 94.0
vacA s1, 2 (166) 1 (0.6) 4 0 (0) 1 160 (97.0) 96.4
vacA s1a, b (142)d 4 (2.8) 32 10 (31) 1 115 (83.3) 81.0
a

Correct determination of status (including those with NB found as false-negative results).

b

Percentage in which mixed infection results were identical between the two methods.

c

Percentage in which results were identical between the two methods (excluding those with NB).

d

Does not include s2 genotypes.

Direct PCR from biopsy specimens tended to underestimate the prevalence of a specific virulence factor such as cagA (e.g., in 14 cases, or 8.4%, NB was detected with cagA, although the culture showed infection with a cagA-positive strain) (Table 4). All of these cases had low H. pylori density by histology (data not shown), suggesting that low H. pylori density in biopsy specimens may result in misleading results with direct PCR. Partial deletion of the cag PAI could also yield cagA-negative and cag empty-site-negative results (i.e., NB). However, because bacterial DNA yielded positive cagA results for the same cases, the possibility of a partially deleted cag PAI is thought to be rare.

Cases with inconsistent genotypes were fortunately rare (Table 4): all such cases had very low H. pylori density by histology, and the positive bands were faint (data not shown), suggesting that there was insufficient DNA from the biopsy samples to correctly genotype these cases. Direct PCR analysis of gastric biopsy specimens is less tedious and time-consuming than culturing of the strains, and it is theoretically possible to perform genotyping from formalin-fixed paraffin-embedded gastric biopsy specimens (7). Clinically, it would be important to include positive and negative controls to exclude the possibility of inhibitors of the PCR in the tissue sample. The use of real-time PCR or Southern hybridization might also provide improved results.

REFERENCES

  • 1.Atherton, J. C., P. Cao, R. M. Peek, M. K. R. Tummuru, M. J. Blaser, and T. L. Cover. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J. Biol. Chem. 270:17771-17777. [DOI] [PubMed] [Google Scholar]
  • 2.Atherton, J. C., K. T. Tham, R. M. Peek, T. L. Cover, and M. J. Blaser. 1996. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J. Infect. Dis. 174:552-556. [DOI] [PubMed] [Google Scholar]
  • 3.Blaser, M. J., G. I. Perez-Perez, H. Kleanthous, T. I. Cover, R. M. Peek, and P. H. Chyou. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111-2115. [PubMed] [Google Scholar]
  • 4.Censini, S., C. Lange, Z. Xiang, J. E. Crabtree, P. Ghiara, M. Borodovsky, R. Rappuoli, and A. Covacci. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93:14648-14653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hulten, K., S. W. Han, H. Enroth, P. D. Klein, A. R. Opekun, R. H. Gilman, D. G. Evans, L. Engstrand, D. Y. Graham, and F. A. El-Zaatari. 1996. Helicobacter pylori in the drinking water in Peru. Gastroenterology 110:1031-1035. [DOI] [PubMed] [Google Scholar]
  • 6.Mukhopadhyay, A. K., D. Kersulyte, J.-Y. Jeong, S. Datta, Y. Ito, A. Chowdhury, S. Chowdhury, A. Sandra, S. K. Bhattacharya, T. Azuma, B. Nair, and D. E. Berg. 2000. Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India. J. Bacteriol. 182:3219-3227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Scholte, G. H. A., L. J. van Doorn, W. G. V. Quint, and J. Lindeman. 2001. Genotyping of Helicobacter pylori strains in formalin-fixed or formaledhyde-sublimate-fixed paraffin-embedded gastric biopsy specimens. Diagn. Mol. Pathol. 10:166-170. [DOI] [PubMed] [Google Scholar]
  • 8.van Doorn, L. J., C. Figueriedo, R. Sanna, A. Plaisier, P. Schneeberger, W. D. Boer, and W. Quint. 1998. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 115:58-66. [DOI] [PubMed] [Google Scholar]
  • 9.Yamaoka, Y., T. Kodama, O. Gutierrez, J. G. Kim, K. Kashima, and D. Y. Graham. 1999. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J. Clin. Microbiol. 37:2274-2279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Yamaoka, Y., T. Kodama, M. Kita, J. Imanishi, K. Kashima, and D. Y. Graham. 1999. Relation between clinical presentation, Helicobacter pylori density, interleukin-1β and -8 production, and cagA status. Gut 45:804-811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Yamaoka, Y., T. Kodama, M. Kita, J. Imanishi, K. Kashima, and D. Y. Graham. 1998. Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter 4:241-253. [DOI] [PubMed] [Google Scholar]
  • 12.Yamaoka, Y., H. M. T. El-Zimaity, O. Gutierrez, N. Figura, J. G. Kim, T. Kodama, K. Kashima, and D. Y. Graham. 1999. Relationship between subtypes of the cagA 3′ repeat region, gastric histology, and susceptibility to low pH. Gastroenterology 117:342-349. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES